These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Fibrin resistance to lysis in patients with pulmonary hypertension other than thromboembolic. Miniati M; Fiorillo C; Becatti M; Monti S; Bottai M; Marini C; Grifoni E; Formichi B; Bauleo C; Arcangeli C; Poli D; Nassi PA; Abbate R; Prisco D Am J Respir Crit Care Med; 2010 May; 181(9):992-6. PubMed ID: 20075386 [TBL] [Abstract][Full Text] [Related]
5. Fibrinogen Aα Thr312Ala polymorphism specifically contributes to chronic thromboembolic pulmonary hypertension by increasing fibrin resistance. Li JF; Lin Y; Yang YH; Gan HL; Liang Y; Liu J; Yang SQ; Zhang WJ; Cui N; Zhao L; Zhai ZG; Wang J; Wang C PLoS One; 2013; 8(7):e69635. PubMed ID: 23894515 [TBL] [Abstract][Full Text] [Related]
6. Advances in understanding the pathogenesis of chronic thromboembolic pulmonary hypertension. Lang I Br J Haematol; 2010 May; 149(4):478-83. PubMed ID: 20331466 [TBL] [Abstract][Full Text] [Related]
7. Analysis of plasmin generation and clot lysis of plasma fibrinogen purified from a heterozygous dysfibrinogenemia, BbetaGly15Cys (Hamamatsu II). Kamijyo Y; Hirota-Kawadobora M; Yamauchi K; Terasawa F; Honda T; Ikeya M; Okumura N Blood Coagul Fibrinolysis; 2009 Dec; 20(8):726-32. PubMed ID: 19809304 [TBL] [Abstract][Full Text] [Related]
8. Fibrin derived from patients with chronic thromboembolic pulmonary hypertension is resistant to lysis. Morris TA; Marsh JJ; Chiles PG; Auger WR; Fedullo PF; Woods VL Am J Respir Crit Care Med; 2006 Jun; 173(11):1270-5. PubMed ID: 16514114 [TBL] [Abstract][Full Text] [Related]
9. Abnormal fibrin clot architecture in nephrotic patients is related to hypofibrinolysis: influence of plasma biochemical modifications: a possible mechanism for the high thrombotic tendency? Colle JP; Mishal Z; Lesty C; Mirshahi M; Peyne J; Baumelou A; Bensman A; Soria J; Soria C Thromb Haemost; 1999 Nov; 82(5):1482-9. PubMed ID: 10595642 [TBL] [Abstract][Full Text] [Related]
10. In vitro fibrin clot formation and fibrinolysis using heterozygous plasma fibrinogen from gammaAsn319, Asp320 deletion dysfibrinogen, Otsu I. Terasawa F; Kani S; Hongo M; Okumura N Thromb Res; 2006; 118(5):651-61. PubMed ID: 16412498 [TBL] [Abstract][Full Text] [Related]
11. The incidence of recurrent venous thromboembolism and chronic thromboembolic pulmonary hypertension following a first episode of pulmonary embolism. Poli D; Miniati M Curr Opin Pulm Med; 2011 Sep; 17(5):392-7. PubMed ID: 21743331 [TBL] [Abstract][Full Text] [Related]